Venetoclax and Decitabine in R/R T-ALL

Clinical trial NCT06712121 · RECRUITING

Trial details

NCT number: NCT06712121
Sponsor: Seoul National University Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

T Lymphoblastic Leukemia/Lymphoma

Start date: 2025-01-30
Primary completion: 2027-08-31
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.